Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMAS: Seretide Mechanism in COPD
NCT00974805Phase 4Completed
- Sponsor
- University of Southampton
- Start
- Feb 2010
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone propionate nasal spray, salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by University of Southampton. Started Feb 2010; status: completed.
02
Drugs
fluticasone propionate nasal spraysalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00974805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974805.